Filmmaker Vishal Bhardwaj has decided to reschedule his upcoming project featuring Irrfan Khan, considering the actor's health issues.
Calling Irrfan, who is suffering from neuroendocrine tumour, a warrior the director said the team will wait for the actor to return from abroad, where he has gone for treatment.
"Irrfan is a warrior and we know he will conquer this battle. Therefore Deepika Padukone, Prernaa (producer) and I have decided to reschedule our film and start with renewed energy and celebration when our warrior returns as a winner," Bhardwaj tweeted.
The director-actor duo have previously worked together in "Maqbool", "7 Khoon Maaf" and "Haider", while Deepika and Irrfan have earlier collaborated on "Piku".
The yet to titled project will be produced by KriArj Entertainment and Vishal Bhardwaj Pictures.
The film was earlier scheduled to go on floors in February end.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
